Open access · OA via Europe PMC

Plasminogen Activator Inhibitor-1 as a Therapeutic Target for Healthy Longevity, Immunosenescence, and Age-Related Disease: Translational Development of the Small-Molecule Inhibitor TM5614

Authors not listed

Cells · 2026

Cellular senescence

＋ Sign in to save

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: Europe PMC
Canonical: link ↗
Fetched: 2026-05-31 MST

Cite this

APA

Anonymous. (2026). Plasminogen Activator Inhibitor-1 as a Therapeutic Target for Healthy Longevity, Immunosenescence, and Age-Related Disease: Translational Development of the Small-Molecule Inhibitor TM5614. <em>Cells</em>. https://europepmc.org/article/PMC/PMC13204133

Vancouver

Anonymous. Plasminogen Activator Inhibitor-1 as a Therapeutic Target for Healthy Longevity, Immunosenescence, and Age-Related Disease: Translational Development of the Small-Molecule Inhibitor TM5614. Cells. 2026.

BibTeX

@article{anon2026Plasmi, title = {Plasminogen Activator Inhibitor-1 as a Therapeutic Target for Healthy Longevity, Immunosenescence, and Age-Related Disease: Translational Development of the Small-Molecule Inhibitor TM5614}, author = {Anonymous}, journal = {Cells}, year = {2026}, }